Clinical Trials on Plasma Volume Replacement in Australia

Total 286 results

Eli Lilly and Company

Completed

New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery

Total Hip Replacement | Total Knee Replacement

Australia, Austria, Belgium, Czech Republic, Germany, Hungary, Italy, Poland
Allergan

Completed

Safety and Efficacy of Juvederm® VOLUMA™ for Correction of Mid-face Volume Deficiency

Mid-face Volume Deficiency

Australia
Medical University of Vienna

Completed

Management of Fluid Overload in TAVR (EASE-TAVR)

Volume Overload

Austria
LG Chem

Completed

Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline Contouring

Jaw Volume Deficit

Austria, Poland
Zimmer Biomet

Withdrawn

Prospective Data Collection on Cementless Oxford Partial Knee

Arthroplasty, Replacement, Knee

Australia
Croma-Pharma GmbH
FGK Clinical Research GmbH

Completed

A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit (PRIMAvera)

Midface Volume Deficit

Austria, Germany
University of Melbourne

Completed

A Targeted Strengthening Program Following Total Hip Replacement.

Total Hip Joint Replacement

Australia
Zimmer Biomet

Terminated

Signature Personalised Patient Care System With the Vanguard Knee System Study

Arthroplasty, Replacement, Knee

Australia, Denmark, United Kingdom, Sweden, Netherlands, United States, Austria, Belgium, France, Portugal
eXIthera Pharmaceuticals
Syneos Health; CPR Pharma Services Pty Ltd, Australia; IDT CMAX Clinical Trials

Completed

Study to Evaluate Safety, PK and PD of Single and Multiple Ascending Doses of EP-7041 in Healthy Subjects

Arthroplasty, Replacement, Knee

Australia
Fairfield Hospital, Australia

Terminated

Short- Versus Long-duration Tourniquet Use During Total Knee Replacement (TKR)

Arthroplasty, Replacement, Knee

Australia
Croma-Pharma GmbH
Proinnovera GmbH

Completed

THIODERM STRONG Compared to Juvéderm® VOLUMA® Lidocaine for the Treatment of Midface Volume Deficit (TIMI)

Mid Face Volume Deficit

Austria
Medical University of Vienna
Klinik Favoriten

Recruiting

The Enteral Resuscitation In Intensive Care Pilot- Study (ERI)

Volume Overload | Hyperosmolality | Electrolyte Imbalance

Austria
Klaus Widhalm
Orthopedic Hospital Vienna Speising

Recruiting

Efficacy of Real-time Feedback Exercise Therapy in Patients Following Total Hip Arthroplasty

Hip Replacement

Austria
Medical University of Vienna

Completed

Effects of Hormone Replacement Therapy on the Serotonergic System and Mood in Postmenopausal Women

Hormone Replacement

Austria
Landesklinikum Sankt Polten

Unknown

Prolongation of Pain Free Time by the Use of Dexamethasone in Peripheral Nerve Blockade

Dexamethasone | Interscalene Block | Shoulder Arthroscopy | Low Volume Regional Anesthesia

Austria
Smith & Nephew, Inc.

Recruiting

Study to Evaluate the Safety and Effectiveness of the REAL INTELLIGENCE™ CORI™ in Total Knee Arthroplasty (TKA) Procedure (CORI RCT TKA)

Arthroplasty | Knee | Replacement

New Zealand, Australia, China, Hong Kong
Stryker Orthopaedics

Completed

Scorpio NRG (eNeRGize) Cruciate Retaining (CR) Post-market International Outcome Study (Scorpio NRG)

Arthroplasty, Replacement, Knee

Netherlands, United Kingdom, Austria, Germany
Medical University of Vienna

Recruiting

Multiple-dose Pharmacokinetics of Ceftaroline During Continuous and Intermittent Renal Replacement Therapy in Patients Requiring Renal Replacement Therapy

Infection During Renal Replacement Therapy

Austria
Medical University of Vienna

Completed

Multiple-dose Pharmacokinetics of Doripenem During Continuous Venovenous Hemodiafiltration and Molecular Adsorbent Recirculating System in ICU Patients and During Hemodialysis in Longterm Hemodialysis Patients.

Infections During Organ Replacement Therapy

Austria
Global Orthopaedic Technology
LSS Surgical Pty Ltd

Unknown

Prophecy Guide Outcomes in Total Knee Replacement Surgery

Osteoarthritis of the Knee | Total Knee Replacement

Australia
Boston Scientific Corporation

Completed

REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System

Transcatheter Aortic Valve Replacement

Spain, United Kingdom, Australia, France, Germany, Italy, Netherlands, Sweden, Switzerland
Medical University Innsbruck

Completed

Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation

Acute Kidney Injury | Critically Ill | Renal Replacement Therapy | Continuous Renal Replacement Therapy | Continuous Veno-Venous Hemofiltration | Replacement Fluid | Phoxilium | Biphozyl | Anticoagulation | Regional Citrate Anticoagulation

Austria
Wellspect HealthCare

Completed

Comparison in Need for Bank Blood Between Patients Undergoing Total Hip Surgery That Either Receive Their Own Blood Back or Not

Blood Transfusion | Arthroplasty, Replacement, Hip | Blood Transfusion, Autologous

Austria, Netherlands, Norway, Spain
Baxter Healthcare Corporation

Completed

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement

Hip Replacement Surgery

Austria, Germany, Netherlands
Omeros Corporation

Terminated

Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery

Intraocular Lens Replacement | Intraoperative Floppy Iris Syndrome

Austria, Germany
Medtronic Bakken Research Center

Completed

Hemodynamic Assessment of Mosaic Ultra Stented Heart Valve in the Aortic Position

Coronary Artery Bypass Grafting | Aortic Valve Replacement

Belgium, Israel, Germany, Austria, Italy
Medical University of Graz
Alphamed Medizintechnik Fischer GmbH

Withdrawn

Comparison of CoCr Alloy and TiN Coating in TKA

Osteoarthritis, Knee | Arthroplasty, Replacement, Knee

Austria
Kepler University Hospital
Medtronic

Completed

Impact of Pacing Mode and Diastolic Function on Cardiac Output (PADIAC)

Diastolic Function | Cardiac Output | AV Block | Pacemaker Stimulation Mode | Stroke Volume

Austria
Boehringer Ingelheim

Terminated

Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery

Venous Thromboembolism | Arthroplasty, Replacement

Austria
Medical University of Vienna

Completed

Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters

Glomerular Filtration Rate | Fatty Acids, Nonesterified | Renal Circulation | Renal Plasma Flow

Austria
University Hospital Muenster
Baxter Healthcare Corporation

Recruiting

Filter Lifespan in Continuous Renal Replacement Therapy (CRRTInfO)

Infections | Critically Ill | Continuous Renal Replacement Therapy

Germany, Austria, Brazil
Boehringer Ingelheim

Completed

RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery

Thromboembolism | Arthroplasty, Replacement, Knee

Australia, Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Poland, South Africa, Spain, Sweden
Celgene Corporation

Completed

A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma

Multiple Myeloma

Ireland, Spain, Australia, Austria, United Kingdom
Bayer
Janssen Research & Development, LLC

Terminated

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes (GALILEO)

Transcatheter Aortic Valve Replacement

Belgium, France, Germany, Spain, United States, Switzerland, Canada, Austria, United Kingdom, Korea, Republic of, Denmark, Italy, Netherlands, Poland, Czechia, Sweden, Norway
Boehringer Ingelheim

Completed

Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery

Thromboembolism | Arthroplasty, Replacement, Hip

Australia, Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, South Africa, Spain, Sweden
AO Innovation Translation Center
AO Foundation, AO Spine

Recruiting

Primary Tumor Research and Outcomes Network (PTRON)

Spinal Column Tumor

United States, Canada, Italy, Australia, China, Germany, Hungary, Japan, United Kingdom
Bayside Health

Terminated

Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Australia
Melbourne Health

Recruiting

Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation (VICTORY)

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Plasma Cell Myeloma | Non-hodgkin Lymphoma | Leukemia, Lymphoblastic, Acute, L1 | Leukemia, Lymphoblastic, Acute, L2

Australia
Pulmonx International Sàrl

Completed

Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study (IMPACT)

COPD Patients With Homogeneous Emphysema | Endoscopic Lung Volume Reduction With Endobronchial Valve

Germany, Austria, Netherlands
Peter MacCallum Cancer Centre, Australia
Celgene Corporation

Unknown

A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression

Multiple Myeloma

Australia
GlaxoSmithKline

Withdrawn

A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma

Cancer

Australia
Peter MacCallum Cancer Centre, Australia
Celgene Corporation; Janssen-Cilag Ltd.

Unknown

A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma

Multiple Myeloma

Australia
Bayside Health

Unknown

Atorvastatin in Myeloma

Myeloma

Australia
Peter MacCallum Cancer Centre, Australia
Melbourne Health

Completed

NMP in Relapsed / Refractory Myeloma

Multiple Myeloma

Australia
Peter MacCallum Cancer Centre, Australia
Janssen, LP

Recruiting

CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study (CARAMEL)

Extramedullary Myeloma

Australia
Ichnos Sciences SA

Not yet recruiting

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

Australia
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

Lymphoma | Multiple Myeloma

Australia
Corcym S.r.l

Terminated

Safety and Effectiveness Study of Perceval S Valve for Extended CE Mark (CAVALIER)

Aortic Valve Replacement

Belgium, Germany, Netherlands, France, Austria, Poland, Switzerland, United Kingdom
AbbVie

Withdrawn

A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment

Multiple Myeloma

Australia
Cancer Trials Australia
Human Genome Sciences Inc.

Unknown

A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia

Symptomatic Waldenstroms Macroglobulinaemia

Australia

Clinical Trials on Plasma Volume Replacement in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations